KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of MNOV
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

MediciNova stock price ended at $1.32 on Thursday, after losing 2.58%.
(Updated on Apr 25, 2024)

Sell candidate since Apr 18, 2024 Loss -5.71% PDF

The MediciNova stock price fell by -2.58% on the last day (Thursday, 25th Apr 2024) from $1.36 to $1.32. During the last trading day the stock fluctuated 3.79% from a day low at $1.32 to a day high of $1.37. The price has fallen in 8 of the last 10 days and is down by -15.38% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -4 thousand shares and in total, 4 thousand shares were bought and sold for approximately $5.74 thousand.

The stock has broken the wide and weak rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $1.33. A reaction back to this level may hold a second chance to get out before further falls.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

MNOV Signals & Forecast

There are few to no technical positive signals at the moment. The MediciNova stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.37 and $1.42. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, April 12, 2024, and so far it has fallen -15.92%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for MediciNova stock

MediciNova finds support from accumulated volume at $1.30 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day, but be aware of low or falling volume as this increases the risk. During the last day, the stock moved $0.0500 between high and low, or 3.79%. For the last week the stock has had daily average volatility of 4.38%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (MNOV) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect MediciNova to open at $1.34, and during the day (based on 14 day Average True Range), to move between $1.25 and $1.39, which gives a possible trading interval of +/-$0.0714 (+/-5.41%) up or down from last closing price. If MediciNova takes out the full calculated possible swing range there will be an estimated 10.82% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $1.30 (1.52%) than the resistance at $1.35 (2.27%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is MediciNova stock A Buy?

The MediciNova stock holds several negative signals and despite the positive trend, we believe MediciNova will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.008 Sell Candidate Unchanged

Predicted Opening Price for MediciNova of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$1.34 ( 1.26%) $1.32

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for MNOV

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.39 5.05 %
R2 1.37 3.60 %
R1 1.36 2.71 %
Current price: 1.32
Support S1 1.32 -0.184 %
S2 1.31 -1.08 %
S3 1.29 -2.53 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.47 11.36 %
R2 1.36 3.03 %
R1 1.35 2.27 %
Current price 1.32
Support S1 1.30 -1.52%
S2 1.29 -2.27%
S3 1.28 -3.03%

FAQ

What is the symbol for MediciNova Stock and on which exchange is it traded?
The symbol for MediciNova is MNOV and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell MediciNova Stock?
The MediciNova stock holds several negative signals and despite the positive trend, we believe MediciNova will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy MediciNova Stock?
MediciNova Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy MediciNova Stock.

What's the current price of MediciNova Stock?
As of the end of day on the Apr 25, 2024, the price of an MediciNova (MNOV) share was $1.32.

What is the 52-week high and low for MediciNova Stock?
The 52-week high for MediciNova Stock is $2.66 and the 52-week low is $1.26.

What is the market capitalization of MediciNova Stock?
As of the Apr 25, 2024, the market capitalization of MediciNova is 64.741M.

When is the next earnings date for MediciNova?
The upcoming earnings date for MediciNova is May 09, 2024.
Click to get the best stock tips daily for free!

About MediciNova

MediciNova MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced periphera... MNOV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT